乌兰巴托协议:修订亚洲的糖尿病术语,以打击耻辱
Yutaka Seino1,2, Daisuke Yabe2,3, Kazuhiro Tsumura4
1Kansai Electric Power Hospital, Osaka, Japan.
Journal of diabetes investigation
|October 4, 2024
概括
亚洲国家因糖尿病术语引用"糖和尿液"而面临耻辱. 达成共识,修订这些条款,并计划在2025年亚洲糖尿病研究协会会议上进行进一步讨论.
科学领域:
- 内分泌学和代谢性疾病.
- 公共卫生和耻辱研究
背景情况:
- 糖尿病术语在全球范围内有所不同,一些亚洲国家使用与"糖"和"尿液"相关的术语,使污名化延续.
- 日本,中国和韩国等地区的现有术语有助于对糖尿病患者的负面看法和歧视.
研究的目的:
- 解决与亚洲糖尿病相关术语相关的耻辱问题.
- 促进关于修订目前在亚洲国家使用的污名化术语的共识.
- 为了促进持续的对话和跟踪进展,以便更新术语.
主要方法:
- 在第16届亚洲糖尿病研究协会 (AASD) 科学会议期间举行了一场联合研讨会.
- 参与了来自AASD和日本糖尿病教育和护理协会的专家的深入讨论.
- 重点是分析不同亚洲地区的糖尿病相关术语及其相关的耻辱感.
主要成果:
- 参与者达成共识,认为有必要修改亚洲普遍存在的污名化糖尿病术语.
- 达成协议,继续就这个问题进行合作讨论.
结论:
- 修改亚洲的污名化糖尿病术语对于减少患者的污名化至关重要.
- 计划在未来的AASD会议上继续参与和监测,以确保进展.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
515
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
515
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Pathophysiology of Diabetes
894
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894
Hypoglycemia and Glucagon
206
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
206


